EARLY RHEUMATOID ARTHRITIS: DIAGNOSIS AND TREATMENT ALGORITHMS
- Authors: Shostak N.A.1, Muradyants A.A.1, Shostak NA1, Muradyants AA1
-
Affiliations:
- Issue: No 11 (2011)
- Pages: 61-66
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278933
- ID: 278933
Cite item
Full Text
Abstract
The review is dedicated to the problems of diagnosis and treatment of early rheumatoid arthritis (RA). Some new diagnostic criteria for RA (ACR/EULAR, 2010), recommendations for the management of patients with early arthritis, and basic principles of therapy of this disease by synthetic disease-modifying anti-rheumatic drugs and biologics are presented. It is emphasized that basic therapy is most effective in the early stage of RA, especially the first 3 months of the onset of the disease. The basis of management of patients with early RA is the close monitoring of the adequacy of the treatment (at least 1 time in 3 months) with subsequent correction of treatment, if necessary.
About the authors
Nadezhda Aleksandrovna Shostak
Anaida Arsent'evna Muradyants
N A Shostak
A A Muradyants
References
- Ревматология: клинические рекомендации / Под ред. РАМН Е.Л. Насонова. М., 2011. С. 90-230
- Symmons D, Tricker K, Roberts C, Et al. The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. Health Technol Assess 2005;9(34):1-78.
- Фоломеева О.М., Галушко Е.А., Эрдес Ш.Ф. Распространенность ревматических заболеваний в популяции населения России и США // Научно-практическая ревматология 2008. № 4. C. 4-14.
- Scott DL, Symmons DP, Coulton BL, et al. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1987;1(8542):1108-11.
- Sharp JT. Speculations on Why Early Treatment of Rheumatoid Arthritis Is Uniquely Effective. J Rheumatol 2008;35:2090-93.
- Vermeer M, Kuper H, Hoekstra M, et al. Implementation of a treat to target strategy in very early rheumatoid arthritis: Results of the DREAM remission induction cohort. Arthritis Rheum 2011;doi: 10.1002/art.30494.
- Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 1988;31:315-24.
- Мурадянц А.А. Ранний ревматоидный артрит: клинико-лабораторные и инструментальные аспекты диагностики. Автореф. дис. на соиск. канд. мед.наук. Ярославль, 2000. C. 29.
- Каратеев Д.Е., Олюнин Е.Л., Лучихина Ю.А. Новые классификационные критерии ревматоидного артрита ACR/EULAR 2010 - шаг вперед к ранней диагностике // Научно-практическая ревматология 2011. № 1. C. 10-15.
- Corrao S, Calvo L, Licata G. The new criteria for classification of rheumatoid arthritis: what we need to know for clinical practice. Eur J Int Med 2011;22:217-19.
- Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-88.
- Mjaavatten MD, Haugen AJ, Helgetveit K,. et al. Pattern of joint involvement and other disease characteristics of 364 patient with arthritis of less than 16 weeks duration. J Rheumatol 2009;36:1401-06.
- Scottish Intercollegiate Guidelines Network. Management of early rheumatoid arthritis. A national clinical guideline. Edinburgh: SIGN; 2011:27p. http://www.sign.ac.uk
- Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34-45.
- Emery P, Breedveld FC, Dougados M, et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61(4):290-97.
- Kosta PE, Voulgari PV, Zikou AK, et al. The usefulness of magnetic resonance imaging of the hand and wrist in very early rheumatoid arthritis. Arth Res Ther 2011;13:R84doi: 10.1186/ar3355.
- Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69(4):631-37.
- Targeted treatment of the rheumatic diseases/ edited by M.H. Weisman,M.E. Weinblatt, J.S. Louie, R.F. van Vollenhoven: Published by W.B. Saunders Company 2009;1-45.
- Peris F, Bird HA, Serni U, et al. Treatment compliance and safety of aceclofenac versus standard NSAIDs in patients with common arthritic disorders: a meta-analysis. Eur J Rheumatol Inflamm 1996;16:37-45.
- Шостак Н.А. Ревматоидный артрит: современные подходы к лечению // Клиницист 2007. № 1. С. 4-12.
- Kuriya B, Arkema E, Bykerk V, et al. Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthiritis: a meta-analysis of clinical and radiographic remission. Ann Rheum Dis 2010;69(7):1298-1304.
- Katchamart W, Bourre-Tessier J, Donka T, et al. Canadian Recommendations for Use of Methotrexate in Patients with Rheumatoid Arthritis. J Rheumatol 2010;37(7):1422-30.
- Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
- Saag K, Teng G, Patkar N, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying ant rheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762-84.
- Диагностика туберкулезной инфекции при планировании и проведении терапии блокаторами у больных ревматическими заболеваниями: Пособие для врачей. Ред. М.И. Перельман, Е.Л.Насонов. М., 2008. 40 с.
- Le Goff B, Berthelot JM, Maugars Y, et al. Alternative use of bisphosphonate therapy for rheumatic disease. Curr Pharm Des 2010;16(27):3045-52.
- Soejima M, Kawaguchi Y, Hara M. Therapeutic Effects of Alendronate on Bone Erosion and Atrophy in a Patient with RA and HCV Infection. J Rheumatol 2008;35:2284-85.
- Suzuki Y. Secondary osteoporosis. Bisphosphonates as a possible strategy for the prevention of bone destruction in rheumatoid arthritis. Clin Calcium 2007;17(12):1909-13.